Jolynn Tumolo

News

Identifying Barriers to PrEP Uptake, Adherence for Transgender Patients

07/22/2022

Lack of trust in the health care system and concerns over medication interactions were among several barriers to PrEP adherence for transgender patients in the United States.

Lack of trust in the health care...

07/22/2022

First Report Managed Care

News

Phase 3 Trial Shows Efficacy of Extended-Release Amphetamine Tablets in Adult ADHD

08/15/2022

Jolynn Tumolo ;

Adults with ADHD who took amphetamine extended-release tablets had statistically significant improvement in symptoms.

Adults with ADHD who took...

08/15/2022

Psych Congress Network

News

Reviewing Treatment Patterns, Economic Burden of Hypertrophic Cardiomyopathy

09/06/2022

Jolynn Tumolo ;

"More effective therapies are needed to stabilize or decrease the economic burden of obstructive hypertrophic cardiomyopathy," concluded study authors.

"More effective therapies are...

09/06/2022

First Report Managed Care

News

Parkinson Disease Pain More Severe in Women

09/27/2022

Jolynn Tumolo ;

Study authors examined the effect of gender on the different pain subtypes in patients with Parkinson disease.

Study authors examined the...

09/27/2022

Annals of Long-Term Care

News

Bronchodilator Recalled

10/14/2022

Jolynn Tumolo ;

A Class II recall has been issued for 103,150 vials of a prescription bronchodilator following the report of a hair found in a vial.

A Class II recall has been...

10/14/2022

Pharmacy Learning Network

News

Brain Samples Reveal Sex-Specific Epigenetic Changes in Mid-Stage Parkinson Disease

11/07/2022

Jolynn Tumolo ;

The epigenetic changes associated with Parkinson disease differ in men and women, according to study findings published in NPJ Parkinson’s Disease. “In this genome-wide analysis of DNA methylation in an enriched neuronal population...

The epigenetic changes...

11/07/2022

Neurology

News

Treatment Improves Narcolepsy Symptoms, Reduces Medication Consumption

11/22/2022

Jolynn Tumolo ;

Study authors examined the safety and effectiveness of pitolisant in patients with type I narcolepsy who did not tolerate or respond to previous treatments.

Study authors examined the...

11/22/2022

First Report Managed Care

News

Real-World Treatment Patterns, Outcomes in Patients With Double- and Triple-Class R/R Multiple Myeloma

12/15/2022

Jolynn Tumolo ;

Researchers studied a heavily pretreated patient population to determine which drugs were being administered, as well as their impact on overall survival.

Researchers studied a heavily...

12/15/2022

First Report Managed Care

News

FDA Clears Neuromodulation System for Patients With MDD

09/19/2022

Jolynn Tumolo ;

The US Food and Drug Administration has provided Magnus Medical Inc. 510(k) clearance for the SAINT Neuromodulation System for the treatment of MDD in adults who have not achieved adequate improvement from prior antidepressant medications in...

The US Food and Drug...

09/19/2022

Psych Congress Network

News

Memory Designation Does Not Lower Risk of Injury Among Residents With Alzheimer Disease

02/10/2023

Jolynn Tumolo ;

Investigators analyzed rates of emergency department visits for injuries among residents of assisted living facilities with and without memory care designation.

Investigators analyzed rates of...

02/10/2023

Annals of Long-Term Care